Dataset Information


3-Aroyl-1,4-diarylpyrroles Inhibit Chronic Myeloid Leukemia Cell Growth through an Interaction with Tubulin.

ABSTRACT: We designed 3-aroyl-1,4-diarylpyrrole (ARDAP) derivatives as potential anticancer agents having different substituents at the 1- or 4-phenyl ring. ARDAP compounds exhibited potent inhibition of tubulin polymerization, binding of colchicine to tubulin, and cancer cell growth. ARDAP derivative 10 inhibited the proliferation of BCR/ABL-expressing KU812 and LAMA84 cells from chronic myeloid leukemia (CML) patients in blast crisis and of hematopoietic cells ectopically expressing the imatinib mesylate (IM)-sensitive KBM5-WT or its IM-resistant KBM5-T315I mutation. Compound 10 minimally affected the proliferation of normal blood cells, indicating that it may be a promising agent to overcome broad tyrosine kinase inhibitor resistance in relapsed/refractory CML patients. Compound 10 significantly decreased CML proliferation by inducing G2/M phase arrest and apoptosis via a mitochondria-dependent pathway. ARDAP 10 augmented the cytotoxic effects of IM in human CML cells. Compound 10 represents a robust lead compound to develop tubulin inhibitors with potential as novel treatments for CML.


PROVIDER: S-EPMC5430391 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC2893099 | BioStudies
2014-01-01 | S-EPMC3938960 | BioStudies
2016-01-01 | S-EPMC4876029 | BioStudies
2016-01-01 | S-EPMC4817228 | BioStudies
2014-01-01 | S-EPMC4146738 | BioStudies
1000-01-01 | S-EPMC2481545 | BioStudies
2008-01-01 | S-EPMC2440422 | BioStudies
2016-01-01 | S-EPMC4868748 | BioStudies
2017-01-01 | S-EPMC5438702 | BioStudies
2013-01-01 | S-EPMC5528438 | BioStudies